Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 14, 169-172, March 1, 1954]
© 1954 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rambo, O. N.
Right arrow Articles by Eichwald, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rambo, O. N., Jr.
Right arrow Articles by Eichwald, E. J.

Immune Phenomena Elicited by Transplanted Tumors

I. The Participation of the Eye and the Brain*

O. N. Rambo, Jr., R. Fuson, M. Hattori and E. J. Eichwald

( Laboratory Service of the Veterans Administration Hospital, and the Department of Pathology, University of Utah College of Medicine, Salt Lake City, Utah)

Experiments with mouse Sarcoma 37 transplanted heterologously to guinea pigs and with mouse tumor E 0771 transplanted homologously to nonsusceptible mice (Strain A) permit the following conclusions with regard to the isolation of the eye and the brain from systemic immune events:

1. Both the eye and the brain participate in immunity to transplanted heterologous and homologous tumors.
2. This participation is incomplete. There exists a state of relative isolation of these sites, particularly the brain. Not infrequently, a primary inoculation of tumor tissue to eye, brain, or subcutaneous tissue fails to immunize the eye or the brain.
3. Immunization of eye or brain is most effective, in homologous hosts, after subcutaneous inoculation. Subcutaneous inoculation is least effective in heterologous hosts. This apparent contradiction may be explained by the fact that in heterologous hosts subcutaneously inoculated tumors consistently fail to grow and are absorbed in a short period of time, while in most homologous hosts subcutaneous tumors grow sufficiently to cause immunization.

* Aided by a grant from the USPHS, National Cancer Institute.

Received 9/28/53.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1954 by the American Association for Cancer Research.